Bone Mineral Density (BMD): What It Measures & Why It Matters
Understanding BMD
Bone Mineral Density (BMD) quantifies the amount of mineral (primarily calcium hydroxyapatite) per unit area of bone. It is the primary metric for diagnosing osteoporosis and assessing fracture risk.
Measurement
- Unit: g/cm² (areal density) via DXA (Dual-energy X-ray Absorptiometry).
- Sites: Lumbar spine (L1–L4), femoral neck, total hip, forearm (1/3 radius).
- Results: T-score (vs. young adult peak) and Z-score (vs. age-matched).
WHO Classification (Postmenopausal Women & Men ≥50)
- Normal: T-score ≥ -1.0
- Osteopenia (Low Bone Mass): T-score -1.0 to -2.5
- Osteoporosis: T-score ≤ -2.5
- Severe Osteoporosis: T-score ≤ -2.5 + fragility fracture
Clinical Significance
- Each 1 SD decrease in T-score ≈ 1.5–2x increase in fracture risk.
- Guides treatment initiation (bisphosphonates, denosumab, anabolics).
- Monitored every 1–2 years on therapy.
BMD ≠ bone quality (microarchitecture, turnover), but remains the standard clinical tool.
Healthcare Management - Related Articles
- Pharmacy Grants: Supporting Medication Safety & Community Health
- Electronic Medical Records (EMR): Benefits and Drawbacks
- ALS Financial Assistance: Resources & Support for Patients
- MedicAlert: Your Guide to Purchasing Medical Alert Bracelets
- Choosing the Right Healthcare Plan: A Comprehensive Guide
- Track Your VA Disability Claim: A Comprehensive Guide
- Genioplasty CPT Coding: A Guide for Medical Coders
